Bioadaptives (BDPT) Other Operating Expenses (2013 - 2026)

Bioadaptives has disclosed Other Operating Expenses across 13 years of filings, most recently posting $19781.0 for Q1 2026.

• Other Operating Expenses for Q1 2026 came in at $19781.0, down 81.3% year-over-year; the trailing twelve-month figure through Mar 2026 was $148178.0 (down 58.24% YoY), and the FY2025 annual result was $234162.0, down 13.53% from the prior year.
• Other Operating Expenses came in at $19781.0 for Q1 2026 at Bioadaptives, down from $27438.0 in the prior quarter.
• In the past five years, Other Operating Expenses ranged from a high of $105765.0 in Q1 2025 to a low of $8919.0 in Q1 2023.
• The 5-year median for Other Operating Expenses is $42923.0 (2023), against an average of $49289.8.
• Across the five-year window, Other Operating Expenses plunged 87.44% in 2023 and surged 386.03% in 2025, its largest moves.
• Bioadaptives' Other Operating Expenses stood at $10911.0 in 2022, then soared by 113.21% to $23263.0 in 2023, then soared by 238.38% to $78718.0 in 2024, then sank by 65.14% to $27438.0 in 2025, then fell by 27.91% to $19781.0 in 2026.
• The last three Other Operating Expenses figures came in at $19781.0 (Q1 2026), $27438.0 (Q4 2025), and $18569.0 (Q3 2025), per Business Quant data.